Health Insurance - Medicare Supplement Policies - Insurance Producer Commission
Summary
SB956 requires health insurers, referred to in the bill as carriers, to pay the same commission rate to a broker or insurance producer when selling certain Medicare supplement policies, regardless of how the policy is issued. The equal-commission rule applies whether the policy is sold during a guaranteed issue period, an open enrollment period, as an underwritten policy, or under the specified statutory provision for certain Medicare supplement coverage.
The bill applies to Medicare supplement policies issued under § 15-909(b)(6) of the Insurance Article or to individuals at least 65 years old. It adds a new section to Maryland’s Insurance Article and takes effect October 1, 2025. In practical terms, it standardizes compensation for producers selling qualifying Medigap policies and removes commission differences tied to the policy’s issuance category.
Impact
SB956 amends Maryland insurance law by adding § 15-922.1 to the Insurance Article. It does not change Medicare eligibility or coverage terms, but it requires carriers to pay uniform commissions to insurance producers for qualifying Medicare supplement policy sales, eliminating lower or different commission rates based on whether the policy is sold during guaranteed issue, open enrollment, or as an underwritten policy. The affected parties are insurers/carriers and brokers or insurance producers who sell Medigap policies, especially policies issued to older adults and those covered by the referenced statutory provision.
Sentiment
The bill appears to have been broadly supported and noncontroversial in the legislative process. It passed the Senate 46-0 and the House 135-2, indicating strong bipartisan approval. No committee transcript was provided, and the voting margins suggest the measure was viewed as a targeted insurance-market adjustment rather than a major policy dispute.
Contention
No specific committee objections or floor debates are available in the provided record, and the overwhelming vote totals suggest limited contention. Any potential policy concern would likely center on whether requiring equal commissions could affect carrier pricing, producer incentives, or marketing practices for Medicare supplement policies, but the available materials do not show organized opposition or a recorded dispute over those issues.